The Consortium Meeting for the LaserBlood project was held on June 26, 2025, at the Università Campus Bio-Medico di Roma. Partners gathered to review key advancements, including updates on clinical trials, sample collection, and the establishment of a new laboratory at Sapienza University. Strategic discussions covered exploitation opportunities, IP management, and innovation tracking, as well as plasma sample protocols and potential collaborations with industry partners.
The meeting concluded with planning for upcoming events, including participation in Medica 2025, and defining the next milestones for this cutting-edge initiative in early pancreatic cancer detection.
Learn more on LaserBlood’s social accounts:
Instagram: https://www.instagram.com/laserblood_eu/
LinkedIn: https://www.linkedin.com/company/laserblood/?viewAsMember=true
YouTube: https://www.youtube.com/@LaserBloodeu
